WELL Health Technologies (DB:W7V) - Aandelenkoers, Nieuws & Analyse

W7V Overzicht aandelen

WELL Health Technologies Corp. opereert als een praktijkgericht bedrijf voor digitale gezondheidszorg in Canada, de Verenigde Staten en internationaal.

Over het bedrijf

W7V fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	1/6
Prestaties in het verleden	2/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Verhandeld tegen 85.9% onder onze schatting van de reële waarde

De omzet zal naar verwachting met 9.2% per jaar groeien

Dit jaar winstgevend geworden

Risicoanalyse

De winst zal naar verwachting de komende drie jaar met gemiddeld 73.9% per jaar dalen.

Grote eenmalige posten die de financiële resultaten beïnvloeden

Aandeelhouders zijn het afgelopen jaar verwaterd

WELL Health Technologies Corp. Concurrenten

SYNLAB

HMSE:SYAB

€2.5b

Fresenius Medical Care

XTRA:FME

€10.7b

RHÖN-KLINIKUM

XTRA:RHK

€850.1m

Fresenius SE KGaA

XTRA:FRE

€19.1b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor WELL Health Technologies
Historische aandelenkoersen
Huidige aandelenkoers	CA$2.84
52 Week Hoogtepunt	CA$3.30
52 Week Laag	CA$2.32
Bèta	1.2
11 maand verandering	-0.94%
3 maanden verandering	-6.92%
1 Jaar Verandering	10.43%
33 jaar verandering	-37.94%
5 jaar verandering	208.48%
Verandering sinds IPO	1,898.59%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	W7V	DE Healthcare	DE Markt
7D	-5.4%	-1.9%	-1.8%
1Y	10.4%	24.7%	13.2%

Rendement versus industrie: W7V presteerde slechter dan de German Healthcare -sector, die het afgelopen jaar een rendement van 24.7 % opleverde.

Rendement versus markt: W7V presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 13.2 % opleverde.

Prijsvolatiliteit

Is W7V's price volatile compared to industry and market?
W7V volatility
W7V Average Weekly Movement	6.4%
Healthcare Industry Average Movement	3.7%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: W7V heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van W7V is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2010	n/a	Hamed Shahbazi	well.company

WELL Health Technologies Corp. opereert als een op zorgverleners gericht digitaal gezondheidszorgbedrijf in Canada, de Verenigde Staten en internationaal. Het bedrijf biedt omnichannel patiëntendiensten en -oplossingen voor specifieke markten, zoals personeel voor zorgverleners, anesthesie, gastro-intestinale gezondheid, vrouwengeneeskunde, eerstelijnsgezondheidszorg en geestelijke gezondheidszorg. Het bedrijf ontwikkelt, integreert en verkoopt ook zijn eigen suite van technologische software en technologische oplossingen voor medische klinieken en zorgverleners.

WELL Health Technologies Corp. Samenvatting

Hoe verhouden de winst en inkomsten van WELL Health Technologies zich tot de beurswaarde?
W7V fundamentele statistieken
Marktkapitalisatie	€729.38m
Inkomsten(TTM)	€97.20m
Inkomsten(TTM)	€601.97m

7.4x

Koers/Winstverhouding

1.2x

P/S-verhouding

Is W7V overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
W7V resultatenrekening (TTM)
Inkomsten	CA$910.42m
Kosten van inkomsten	CA$505.54m
Brutowinst	CA$404.88m
Overige uitgaven	CA$257.87m
Inkomsten	CA$147.01m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 07, 2024

Winst per aandeel (EPS)	0.59
Brutomarge	44.47%
Nettowinstmarge	16.15%
Schuld/Eigen Vermogen Verhouding	33.6%

Hoe presteerde W7V op de lange termijn?

Bekijk historische prestaties en vergelijking

W7V Overzicht aandelen

Beloningen

Risicoanalyse

WELL Health Technologies Corp. Concurrenten

HMSE:SYAB

€2.5b

XTRA:FME

€10.7b

XTRA:RHK

€850.1m

XTRA:FRE

€19.1b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Second quarter 2024 earnings released: EPS: CA$0.45 (vs CA$0.024 loss in 2Q 2023)

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Investor sentiment improves as stock rises 16%

Recent updates

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Second quarter 2024 earnings released: EPS: CA$0.45 (vs CA$0.024 loss in 2Q 2023)

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Investor sentiment improves as stock rises 16%

New major risk - Revenue and earnings growth

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

First quarter 2024 earnings released: EPS: CA$0.062 (vs CA$0.062 loss in 1Q 2023)

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

New minor risk - Share price stability

Third quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.019 loss in 3Q 2022)

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

Independent Director recently sold €112k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.027 loss in 2Q 2022)

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

First quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.038 loss in 1Q 2022)

WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023

WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice

WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021)

Forecast to breakeven in 2024

Forecast to breakeven in 2024

Third quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.061 loss in 3Q 2021)

WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022

WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022

Independent Director recently sold €267k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Cloud Practice Inc. and 3 Clinics from CloudMD Software & Services Inc. (TSXV:DOC) for CAD 5.75 million.

Independent Director recently sold €116k worth of stock

Second quarter 2022 earnings released: CA$0.027 loss per share (vs CA$0.08 loss in 2Q 2021)

WELL Health Technologies Corp. Updates Revenue Guidance for the Year of 2022

WELL Health Technologies Corp. Announces Appointment of Sybil Lau to its Board of Directors

WELL Health Technologies Corp. Provides Revenue Guidance for the Second Quarter 2022

WELL Appoints Iain Paterson to the Position of Chief Information Security Officer

WELL Health Technologies Corp. (TSX:WELL) entered into an asset purchase agreement to acquire Assets of INLIV Inc. from Coril Holdings Ltd. for CAD 1.8 million.

No longer forecast to breakeven

WELL Health Technologies Corp. has completed a Follow-on Equity Offering in the amount of $30.01107 million.

First quarter 2022 earnings released: CA$0.038 loss per share (vs CA$0.046 loss in 1Q 2021)

WELL Health Technologies Corp. Revises Earnings Guidance for the Year 2022

WELL Health Technologies Corp. to Report Q1, 2022 Results on May 12, 2022

Forecast breakeven date moved forward to 2022

WELL Health Technologies Corp. Provides Preliminary Earning Guidance for the First Quarter Ended March 31, 2022

WELL Health Technologies Corp., Annual General Meeting, Jun 17, 2022